EX-99.2 4 onar_ex992.htm UNAUDITED PRO FORMA CONDENSED CONSOLIDATED FINANCIAL INFORMATION onar_ex992.htm

EXHIBIT 99.2

 

Unaudited Pro Forma Condensed Consolidated Financial Information

Overview

 

On December 31, 2025 (the “Closing Date”), ONAR, LLC (the “Seller”), a subsidiary of ONAR Holding Corporation (the “Company”), entered into an asset purchase agreement (the “Asset Purchase Agreement”) with VMED Consulting, Inc. (the “Buyer”) effective as of December 30, 2025, pursuant to which the Seller agreed to sell, and Buyer agreed to purchase, substantially all of the assets of VMED Services, LLC, a subsidiary of the Company (the “Purchased Assets”), for aggregate consideration of $1,500,000 in the form of a promissory note made in favor of the Seller by the Buyer (the “Promissory Note”), subject to the terms and conditions set forth in the Asset Purchase Agreement (such sale, the “VMED Services Sale”).

 

The Promissory Note shall be payable in monthly installments of $5,000 commencing on January 1, 2026, and continuing through December 30, 2031 (the “Maturity Date”) at which time a final balloon payment of the remaining unpaid principal and accrued interest shall be due and payable in full. The Promissory Note is fully guaranteed by Michael Steven, President of VMED Consulting, Inc., in his individual capacity.

 

The VMED Services Sale does not meet the criteria requiring the presentation of the VMED Services, LLC Business as a discontinued operation in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) and is considered a disposition of a significant business under Item 2.01 of Form 8-K. To facilitate the VMED Services Sale, the Company prepared the accompanying unaudited pro forma condensed consolidated financial statements in accordance with Article 11 of Regulation S-X.

 

The unaudited pro forma condensed consolidated financial information is prepared based upon available information and does not include all of the information and note disclosures required by U.S. GAAP. The accompanying unaudited pro forma condensed consolidated balance sheet as of September 30, 2025 has been prepared giving effect to the VMED Services Sale as if it had occurred on September 30, 2025, the end of the most recent period for which a balance sheet is required. The accompanying unaudited pro forma condensed consolidated statements of operations for the year ended December 31, 2024, and nine months ended September 30, 2025 give effect to the VMED Services Sale as if it had occurred on January 1, 2024.

 

The unaudited pro forma condensed consolidated financial information is provided for illustrative informational purposes only and has been derived from the historical consolidated financial statements of the Company and is presented based on available information and certain assumptions that the Company believes are reasonable and that are described in the accompanying notes. Differences between these preliminary estimates and the final divestiture accounting may arise, and these differences could have a material effect on the unaudited pro forma condensed consolidated financial information and the Company’s future results of operations and financial position. The unaudited pro forma condensed consolidated financial information is not necessarily, and should not be assumed to be, an indication of the actual results that would have been achieved had the VMED Services Sale been completed as of the dates indicated or that may be achieved in the future.

 

The accompanying unaudited pro forma condensed consolidated financial statements should be read together with:

 

 

·

The accompanying notes to the unaudited pro forma condensed consolidated financial statements;

 

·

The Company’s historical condensed consolidated financial statements and the accompanying notes included in the Quarterly Report on Form 10-Q as of and for the nine months ended September 30, 2025, filed with the Securities and Exchange Commission (the “SEC”) on November 14, 2025; and

 

·

The Company’s audited historical consolidated financial statements and the accompanying notes included in the Annual Report on Form 10-K/A as of and for the fiscal year ended December 31, 2024, filed with the SEC on May 5, 2025 and the Company’s audited historical consolidated financial statements and the accompanying notes included in the Annual Report on Form 10-K as of and for the fiscal year ended December 31, 2024, filed with the SEC on April 15, 2025.

 

 
1

 

 

ONAR HOLDING CORPORATION

Unaudited Pro Forma Condensed Consolidated Balance Sheet

As of September 30, 2025

 

 

 

September 30,

 

 

September 30,

 

 

 

2025

 

 

2025

 

 

 

(Historical)

 

 

(Pro Forma)

 

ASSETS

 

 

 

 

 

 

 

 

Current assets:

 

 

 

 

 

 

Cash

 

$ 284,881

 

 

$ 274,840

 

Accounts receivable, net

 

 

220,145

 

 

 

197,116

 

Investments in equity securities

 

 

-

 

 

 

-

 

Investments in equity securities, related party

 

 

41,061

 

 

 

41,061

 

Prepaid expenses and other current assets

 

 

79,127

 

 

 

81,914

 

Total current assets

 

 

625,214

 

 

 

594,931

 

 

 

 

 

 

 

 

 

 

Other assets:

 

 

 

 

 

 

 

 

Property and equipment

 

 

86,069

 

 

 

86,069

 

Intangible assets, net

 

 

267,863

 

 

 

267,863

 

Goodwill

 

 

2,651,883

 

 

 

2,651,883

 

Advances to related party

 

 

110,419

 

 

 

110,847

 

Employee loan receivable, net

 

 

164,022

 

 

 

164,022

 

Advance to affiliated entity

 

 

400,700

 

 

 

270,700

 

Right of use asset

 

 

4,666

 

 

 

4,666

 

Total other assets

 

 

3,685,622

 

 

 

3,556,050

 

 

 

 

 

 

 

 

 

 

Total assets

 

$ 4,310,836

 

 

$ 4,150,981

 

 

 

 

 

 

 

 

 

 

LIABILITIES AND STOCKHOLDERS’ DEFICIT

 

 

 

 

 

 

 

 

 

Current liabilities:

 

 

 

 

 

 

 

 

Accounts payable

 

$ 1,004,686

 

 

$ 969,585

 

Accrued expenses and other liabilities

 

 

2,001,677

 

 

 

1,991,677

 

Lines of credit

 

 

-

 

 

 

-

 

Deferred revenue

 

 

590,486

 

 

 

590,486

 

Contract liabilities

 

 

81,260

 

 

 

81,260

 

Accrued expenses and advances, related party

 

 

-

 

 

 

-

 

Lease liability

 

 

4,762

 

 

 

4,762

 

Notes payable

 

 

2,194,657

 

 

 

2,194,657

 

Notes payable, related party, net of discounts

 

 

1,009,062

 

 

 

1,009,062

 

Convertible notes payable, net of discounts

 

 

2,092,627

 

 

 

2,092,627

 

Total current liabilities and total liabilities

 

 

8,979,217

 

 

 

8,934,116

 

 

 

 

 

 

 

 

 

 

Commitments and contingencies (Note 6)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Stockholders’ Deficit:

 

 

 

 

 

 

 

 

Preferred stock, 5,000,000 shares authorized, $0.001 par value, 0 issued and outstanding as of September 30, 2025 and December 31, 2024, respectively

 

 

-

 

 

 

-

 

Preferred stock Series A, 1,000 shares authorized, $0.001 par value, 1,000 and 1,000 issued and outstanding as of September 30, 2025 and December 31, 2024, respectively

 

 

1

 

 

 

1

 

Preferred stock Series B, 10,000 shares authorized, $0.001 par value, 3,065 and 3,125 issued and outstanding as of September 30, 2025 and December 31, 2024, respectively

 

 

3

 

 

 

3

 

Preferred stock Series C, 6,570 shares authorized, $0.001 par value, 6,570 and 6,570 issued and outstanding as of September 30, 2025 and December 31, 2024, respectively

 

 

7

 

 

 

7

 

Preferred stock, Series D, 100 shares authorized, $0.001 par value, 0 and 100 issued and outstanding as of September 30, 2025 and December 31, 2024, respectively

 

 

-

 

 

 

-

 

Preferred stock Series E, 6,000 shares authorized, $0.001 par value, 660 and 0 issued and outstanding as of September 30, 2025 and December 31, 2024, respectively

 

 

-

 

 

 

-

 

Common stock 1,000,000,000 shares authorized, $0.001 par value., 128,762,167 and 112,380,049 issued and outstanding as of September 30, 2025 and December 31, 2024, respectively

 

 

128,763

 

 

 

128,763

 

Additional paid-in capital

 

 

4,175,335

 

 

 

4,424,908

 

Accumulated deficit

 

 

(8,972,490 )

 

 

(9,336,817 )

Total stockholders’ deficit

 

 

(4,668,381 )

 

 

(4,783,135 )

 

 

 

 

 

 

 

 

 

Total liabilities and stockholders’ deficit

 

$ 4,310,836

 

 

$ 4,150,981

 

 

 
2

 

 

ONAR HOLDING CORPORATION

Unaudited Pro Forma Condensed Consolidated Statement of Operations

For the nine months ended September 30, 2025

 

 

 

Nine Months Ended

September 30,

 

 

 

2025

 

 

Pro Forma

 

 

 

 

 

 

 

 

Revenue (including approximately $-0-, $248,000, $-0- and $470,000 of related party revenue, respectively, Note 4)

 

$ 2,700,340

 

 

$ 2,309,980

 

Cost of revenues

 

 

2,531,743

 

 

 

2,531,743

 

Gross profit

 

 

168,597

 

 

 

(221,763 )

 

 

 

 

 

 

 

 

 

Operating expenses:

 

 

 

 

 

 

 

 

General and administrative

 

 

2,970,268

 

 

 

2,970,268

 

Depreciation and amortization

 

 

237,188

 

 

 

237,188

 

Total operating expenses

 

 

3,207,456

 

 

 

3,034,853

 

 

 

 

 

 

 

 

 

 

Loss from operations

 

 

(3,038,859 )

 

 

(3,256,616 )

 

 

 

 

 

 

 

 

 

Other (income) expense:

 

 

 

 

 

 

 

 

Interest expense

 

 

828,803

 

 

 

828,803

 

Transaction costs for merger

 

 

-

 

 

 

-

 

Other expense (income)

 

 

(24,321 )

 

 

(24,321 )

Change in fair value of investments

 

 

448,139

 

 

 

448,139

 

Total other expense

 

 

1,252,621

 

 

 

1,033,048

 

 

 

 

 

 

 

 

 

 

Provision for income tax

 

 

-

 

 

 

-

 

 

 

 

 

 

 

 

 

 

Net loss

 

$ (4,291,480 )

 

$ (4,289,664 )

 

 

 

 

 

 

 

 

 

Net loss per share-basic and diluted

 

$ (0.03 )

 

$ (0.03 )

 

 

 

 

 

 

 

 

 

Weighted average common shares outstanding

 

 

122,996,729

 

 

 

122,996,729

 

 

 

3

 

 

ONAR HOLDING CORPORATION

Unaudited Pro Forma Condensed Consolidated Statement of Operations

For the year ended December 31, 2024

 

 

 

2024

 

 

Pro Forma

 

 

 

 

 

 

 

 

Revenue (including $81,955 and $606,000 of related party revenue, respectively, Note 5)

 

$ 2,573,386

 

 

$ 2,093,217

 

Cost of revenues

 

 

2,613,942

 

 

 

2,613,942

 

Gross profit (loss)

 

 

(40,556 )

 

 

(520,725 )

 

 

 

 

 

 

 

 

 

Operating expenses:

 

 

 

 

 

 

 

 

General and administrative

 

 

1,354,527

 

 

 

1,152,363

 

Depreciation and amortization

 

 

585,109

 

 

 

460,109

 

Total operating expenses

 

 

1,939,636

 

 

 

1,612,472

 

 

 

 

 

 

 

 

 

 

Loss from operations

 

 

(1,980,192 )

 

 

(2,133,197 )

 

 

 

 

 

 

 

 

 

Other (income) expense:

 

 

 

 

 

 

 

 

Interest expense

 

 

436,861

 

 

 

381,241

 

Transaction costs for merger

 

 

461,115

 

 

 

455,615

 

Other (income) expense

 

 

19,498

 

 

 

19,498

 

Change in fair value of investments

 

 

(178,381 )

 

 

(178,381 )

Loss on extinguishment of notes payable

 

 

363,871

 

 

 

363,871

 

Total other(income)expense

 

 

1,102,964

 

 

 

1,041,844

 

 

 

 

 

 

 

 

 

 

Provision for income tax

 

 

-

 

 

 

-

 

 

 

 

 

 

 

 

 

 

Net loss

 

$ (3,083,156 )

 

$ (3,175,041 )

 

 

 

 

 

 

 

 

 

Net loss per share - basic and diluted

 

$ (0.15 )

 

$ (0.16 )

 

 

 

 

 

 

 

 

 

Weighted average common shares outstanding

 

 

20,181,605

 

 

 

20,181,605

 

 

 
4

 

 

 

Notes to the Unaudited Pro Forma Condensed Consolidated Financial Statements 

 

1. Basis of Pro Forma Presentation

 

The unaudited pro forma condensed consolidated financial statements are prepared in accordance with Article 11 of the Securities and Exchange Commission (the “SEC”) Regulation S-X. The pro forma adjustments are described in the accompanying notes and are based upon and derived from information and assumptions available at the time of filing the Current Report on Form 8-K to which these financial statements and related notes are attached as an exhibit.

 

The unaudited pro forma condensed consolidated financial information is based on financial statements prepared in accordance with U.S. GAAP, which are subject to change and interpretation. The unaudited pro forma condensed consolidated financial statements were based on and derived from our historical consolidated financial statements, adjusted for certain transaction accounting adjustments. The unaudited pro forma condensed consolidated financial information does not give effect to any anticipated synergies, operating efficiencies, tax savings or cost savings that may be associated with the VMED Services Sale.

 

The unaudited pro forma condensed consolidated financial information is based upon available information and assumptions that management considers to be reasonable, and such assumptions have been made solely for purposes of developing such unaudited pro forma condensed consolidated financial information for illustrative purposes in compliance with the disclosure requirements of the SEC. The unaudited pro forma condensed consolidated financial information is not necessarily indicative of what the financial position or statements of operations results would have actually been had the VMED Services Sale occurred on the dates indicated. In addition, these unaudited pro forma consolidated financial statements should not be considered to be indicative of our future consolidated financial performance and statement of operations results.

 

 
5